InsidersTradesSigma
Browse the full management transaction log of Lytix Biopharma ASA, a listed issuer based in Norway. Shares are quoted on NO NO, under the authority of Oslo Børs. Operating in the Healthcare & Pharma sector, Lytix Biopharma ASA has published 15 insider filings. Market capitalisation: €674.4m. The latest transaction was disclosed on 9 April 2026 — Option grant. Among the most active insiders: Norwegian Securities Trading Act.. All data is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations